Reports
Reports
Sale
The growth of the global serum free media market size is being driven by the increasing demand for cell-based vaccines across the globe. The market attained a value of USD 1.43 billion in 2022. The market is anticipated to grow at a CAGR of 10.04% during the forecast period of 2023-2031 to attain a value of USD 3.37 by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is one of the most lucrative serum-free media markets with highest revenue share due to high production and consumption by bio pharmaceuticals in the region. Bio pharmaceutical industry is the key end-user of the market as it invests more in research and development than any other sectors. The industry of high R&D expenditure further focuses on the United States which helps in generating highest revenue through development of innovative bio pharmaceuticals. Increasing adaptation of bio pharmaceuticals for the treatment of various diseases for better therapeutic effect further drives the growth of serum free media market.
Europe is the second most lucrative region in serum free media market thanks to high number of bio pharmaceutical manufacturing companies within the region. Rising spending on clinical trials and academic research using serum free media further expected to strengthen the serum free media market growth. Asia-Pacific serum free media market remains the fastest growing market because of emerging economies like China and India including increasing number of CMOs (contract manufacturing organizations) within the region.
Serum free media (SFM) allows researchers to grow a selected cell type or perform a selected application within the absence of serum. Advantages of using serum free media include a more consistent performance, increased growth and productivity, better control over physiological responsiveness, and to reduce risk of contamination by serum-borne adventitious agents in cell culture.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on media type, the industry can be divided as follows:
The end-uses of the industry can be categorised as follows:
The regional markets can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global serum free media industry will show an upward growth trajectory owing to rise in the number of infections, increase in incidences of chronic diseases, and growth in the geriatric population. It is also worth observing here that a large number of people in the United States suffer from various chronic diseases. The growth of the healthcare sectors in the regions is also significantly contributing to the growth of the industry. All this is often resulting in a rise in demand for immunotherapy, aiding within the growth of serum free media market.
The report gives a detailed analysis of the following key players in the global serum free media market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Media Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Serum Free Media Market Overview
3.1 Global Serum Free Media Market Historical Value (2016-2022)
3.2 Global Serum Free Media Market Forecast Value (2023-2031)
4 Global Serum Free Media Market Landscape
4.1 Global Serum Free Media Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Serum Free Media Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Serum Free Media Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Serum Free Media Market Segmentation
6.1 Global Serum Free Media Market by Media Type
6.1.1 Market Overview
6.1.2 Protein Expression Media
6.1.3 Stem Cell Media
6.1.4 Hybridoma Media
6.1.5 Primary Cell Media
6.1.6 Insect Cell Media
6.1.7 Immunology Media
6.1.8 CHO Cell Culture
6.1.9 Chemically Defined
6.1.10 Others
6.2 Global Serum Free Media Market by End User
6.2.1 Market Overview
6.2.2 Biopharmaceutical Companies
6.2.3 Clinical Research Organisations
6.2.4 Academic Research Centers
6.2.5 Others
6.3 Global Serum Free Media Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Serum Free Media Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Serum Free Media Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Serum Free Media Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Serum Free Media Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Serum Free Media Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Lonza
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Corning Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Nippon Genetics Co. Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 MP Biomedicals LLC
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 PromoCell GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Thermo Fisher Scientific, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 FUJIFILM Holdings Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Illumina, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Sigma Aldrich
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HiMedia Laboratories
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Serum Free Media Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global serum free media market is projected to grow at a CAGR of 7% between 2023 and 2031.
The industry is primarily being driven by thegrowth in the elderly population, growth of the healthcare sectors, rise in demand for immunotherapy, high research and development expenditures, rising spending on clinical trials and academic research, and an increasing number of CMOs (contract manufacturing organisations).
The key trends propelling the industry’s growth are the rise in the number of infections and increase in the incidences of chronic diseases.
The major regions in the industry are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
Based on media type, the industry can be divided into protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, CHO cell culture, and chemically defined, among others.
The end-uses are biopharmaceutical companies, clinical research organisations, and academic research centres, among others.
The major players in the industry are Lonza Group Ltd., Corning Incorporated, Nippon Genetics Co. Ltd., and MP Biomedicals LLC, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.